Table 2:
Treatment modality, average time from diagnosis to treatment and sequence of treatment stratified by risk status (weighted %)
| Treatment Modality | Stratifying by COG Risk Group | |||
|---|---|---|---|---|
| Low (N=36) | Intermediate (N=57) | High (N=100) | Unknown (N=57) | |
| Treatment modality (weighted % by risk group: not mutually exclusive) | ||||
| Surgery (n=207) | 100.0 | 63.2 | 86.0 | 86.2 |
| Chemotherapy (n=203) | 30.4 | 96.7 | 99.1 | 66.7 |
| Radiation (n=105) | 0 | 3.4 | 78.4 | 41.3 |
| Stem Cell Rescue Transplant (n= 104) | 0 | 0 | 83.9 | 34.7 |
| Dinutuximab (n=42) | 0 | 0 | 32.0 | 17.2 |
| Retinoid therapy (n=43) | 0 | 9.4 | 29.9 | 13.9 |
| Mean days from date of diagnosis to: | ||||
| Surgery | 4 | 108 | 117 | 69 |
| Chemotherapy | 99 | 10 | 16 | 40 |
| Radiation | NA | NA | 251 | 250 |
| Stem Cell Rescue Transplant | NA | NA | 180 | 213 |
| Dinutuximab | NA | NA | 300 | 298 |
| Retinoid therapy | NA | 371 | 326 | 321 |
| Sequence of treatment (weighted % by risk group) | ||||
| Systemic therapy before surgery | 2.7 | 31.2 | 16.1 | 11.9 |
| Systemic therapy after surgery | 27.5 | 16.0 | 5.9 | 11.3 |
| Systemic therapy both before & after surgery | 2.9 | 14.4 | 64.0 | 33.1 |
| Radiation after surgery | 0 | 1.6 | 72.6 | 34.5 |
| Radiation after systemic therapy | 0 | 1.6 | 42.4 | 20.5 |
| Radiation after stem cell rescue transplant | 0 | 0 | 62.1 | 25.9 |
| Systemic therapy before & after radiation | 0 | 0 | 27.5 | 17.3 |